Insider · CIK 0001678152

Keyes Jason A

Reports to the SEC for 5 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001678152

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-10	BLSMBlossomHill Therapeutics, Inc.P Purchase	Chief Financial Officer	PPurchase	+700 sh	$16.00	+$11.2K	700
2026-08-06	BLSMBlossomHill Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+56.7K sh	—	—	56,746
2026-05-21	ACTUACTUATE THERAPEUTICS, INC. · Stock OptionsA Award	Director	AAward	+15K sh	—	—	15,000
2025-05-22	ACTUACTUATE THERAPEUTICS, INC. · Stock OptionsA Award	Director	AAward	+15K sh	—	—	15,000
2025-02-14	EQEquillium, Inc. · Employee Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+125K sh	—	—	125,000
2025-02-14	EQEquillium, Inc. · Employee Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+70K sh	—	—	70,000
2025-02-14	EQEquillium, Inc. · Employee Stock Option (right to buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−70K sh	—	—	0
2025-02-14	EQEquillium, Inc. · Employee Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+90K sh	—	—	90,000
2025-02-14	EQEquillium, Inc. · Employee Stock Option (right to buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−90K sh	—	—	0
2025-02-14	EQEquillium, Inc. · Employee Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+100K sh	—	—	100,000
2025-02-14	EQEquillium, Inc. · Employee Stock Option (right to buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−100K sh	—	—	0
2025-02-14	EQEquillium, Inc. · Employee Stock Option (right to buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−175K sh	—	—	0
2025-02-14	EQEquillium, Inc. · Employee Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+175K sh	—	—	175,000
2025-02-14	EQEquillium, Inc. · Employee Stock Option (right to buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−125K sh	—	—	0
2025-01-23	EQEquillium, Inc.S Sale	Chief Financial Officer	SSale	−10K sh	$0.65	−$6,500	37,720
2025-01-02	EQEquillium, Inc. · Employee Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+175K sh	—	—	175,000
2024-12-10	EQEquillium, Inc.A Award	Chief Financial Officer	AAward	+15K sh	$0.54	+$8,100	88,913
2024-09-26	EQEquillium, Inc.S Sale	Chief Financial Officer	SSale	−10K sh	$0.81	−$8,100	57,720
2024-08-12	ACTUACTUATE THERAPEUTICS, INC. · Non-Qualified Stock OptionsA Award	Director	AAward	+30K sh	—	—	30,000
2024-07-16	EQEquillium, Inc.S Sale	Chief Financial Officer	SSale	−10K sh	$0.87	−$8,700	67,720
2024-01-02	EQEquillium, Inc. · Employee Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+175K sh	—	—	175,000
2023-12-08	EQEquillium, Inc.A Award	Chief Financial Officer	AAward	+8,805 sh	$0.58	+$5,106.9	58,913
2023-06-09	EQEquillium, Inc.A Award	Chief Financial Officer	AAward	+15K sh	$0.56	+$8,400	50,108
2023-01-03	EQEquillium, Inc. · Employee Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+175K sh	—	—	175,000
2022-12-09	EQEquillium, Inc.A Award	Chief Financial Officer	AAward	+4,444 sh	$1.19	+$5,288.36	35,108
2022-08-29	EQEquillium, Inc.S Sale	Chief Financial Officer	SSale	−7,000 sh	$2.83	−$19.8K	77,720
2022-06-22	CARMCarisma Therapeutics Inc.A Award	Director	AAward	+40K sh	—	—	40,000
2022-06-22	CARMCarisma Therapeutics Inc. · Stock OptionA Award	Director	AAward	+65K sh	—	—	65,000
2022-06-06	EQEquillium, Inc.S Sale	Chief Financial Officer	SSale	−5,000 sh	$2.52	−$12.6K	84,720
2022-04-04	EQEquillium, Inc.S Sale	Chief Financial Officer	SSale	−8,000 sh	$3.18	−$25.4K	89,720
2022-01-19	EQEquillium, Inc. · Employee Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+125K sh	—	—	125,000
2021-12-10	EQEquillium, Inc.A Award	Chief Financial Officer	AAward	+5,585 sh	$2.35	+$13.1K	23,296
2021-12-01	EQEquillium, Inc.S Sale	Chief Financial Officer	SSale	−5,000 sh	$5.08	−$25.4K	97,720
2021-09-27	EQEquillium, Inc.S Sale	Chief Financial Officer	SSale	−8,000 sh	$6.74	−$53.9K	102,720
2021-07-27	EQEquillium, Inc.S Sale	Chief Financial Officer	SSale	−5,000 sh	$5.72	−$28.6K	110,720
2021-06-10	EQEquillium, Inc.A Award	Chief Financial Officer	AAward	+5,535 sh	$2.35	+$13K	17,711
2021-05-26	EQEquillium, Inc.S Sale	Chief Financial Officer	SSale	−5,000 sh	$6.50	−$32.5K	115,720
2021-05-26	EQEquillium, Inc.S Sale	Chief Financial Officer	SSale	−5,000 sh	$6.50	−$32.5K	115,720
2021-05-03	CARMCarisma Therapeutics Inc. · Stock OptionA Award	Director	AAward	+92.5K sh	—	—	92,500
2021-01-04	EQEquillium, Inc. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+100K sh	—	—	100,000
2020-12-23	EQEquillium, Inc.S Sale	Chief Financial Officer	SSale	−8,000 sh	$4.74	−$37.9K	120,720
2020-12-10	EQEquillium, Inc.J Other	Chief Financial Officer	JOther	+5,362 sh	$2.35	+$12.6K	12,176
2020-06-10	EQEquillium, Inc.J Other	Chief Financial Officer	JOther	+5,014 sh	$2.41	+$12.1K	6,814
2020-05-06	CARMCarisma Therapeutics Inc. · Stock OptionA Award	Director	AAward	+59K sh	—	—	59,000
2020-04-22	EQEquillium, Inc. · Stock Option (right to buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−70K sh	—	—	0
2020-04-22	EQEquillium, Inc. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+70K sh	—	—	70,000
2020-04-22	EQEquillium, Inc. · Stock Option (right to buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−90K sh	—	—	0
2020-04-22	EQEquillium, Inc. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+90K sh	—	—	90,000
2020-02-24	CARMCarisma Therapeutics Inc. · Stock OptionA Award	Director	AAward	+118K sh	—	—	118,000
2020-02-18	EQEquillium, Inc.S Sale	Chief Financial Officer	SSale	−5,000 sh	$5.03	−$25.1K	130,520

Recent filings

Accepted (ET)
Aug 104
Keyes Jason A0001678152-26-000003
SEC(opens sec.gov)
May 224
Keyes Jason A0001683168-26-004245
SEC(opens sec.gov)
May 234
Keyes Jason A0001683168-25-003992
SEC(opens sec.gov)
Feb 194
Keyes Jason A0001415889-25-004756
SEC(opens sec.gov)
Jan 244
Keyes Jason A0001415889-25-002070
SEC(opens sec.gov)
Jan 64
Keyes Jason A0001415889-25-000843
SEC(opens sec.gov)
Sep 274
Keyes Jason A0001415889-24-024079
SEC(opens sec.gov)
Aug 144
Keyes Jason A0001104659-24-089793
SEC(opens sec.gov)
Jul 184
Keyes Jason A0001415889-24-019776
SEC(opens sec.gov)

Companies

Address

C/O BLOSSOMHILL THERAPEUTICS, INC. 10255 SCIENCE CENTER DRIVE, SUITE 200

SAN DIEGO, CA, 92121